FDA Approved: DOCETAXEL — Supplemental Application (Dr. Reddy's Laboratories Inc.)

View source ↗

Summary

FDA approved a supplemental application for Docetaxel from Dr. Reddy's Laboratories Inc., authorizing the generic product under the approved labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Head and Neck Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

SUPPL AP for DOCETAXEL (DOCETAXEL)